Factors affecting the incidence of viral pneumonia in patients with hematological malignancies
https://doi.org/10.18821/0234-5730-2016-61-1-37-42
Abstract
The aim of the study was to analyze clinical significance of herpes viruses DNA monitoring in bronchoalveolar lavage fluid (BALF) of patients with hematological malignancies and pneumonia during or after chemotherapy. Samples of 171 enrolled patients were tested for human cytomegalovirus (CMV) DNA, herpes simplex virus I and II types (HSV) DNA, Epstein-Barr virus (EBV) DNA and human herpes virus 6 type (HV6) DNA. Viral load in BALF was also measured. Factors potentially increasing the rate of reactivation of endogenous herpes viruses have been evaluated. Among them: age of 50 years and over, laboratory sights of immunodeficiency like neutropenia and/or hypogammaglobulinemia, severity of condition/need for admission to ICU. Results. HSV DNA proved the highest detection in BALF frequency. Statistically significant difference for HSV DNA detection rate was obtained (Chi-sq. = 7.65; p = 0.022) for patients with all evaluated factors. HSV 1 and 2 of types were shown to be the most frequently identified viruses. In majority of samples HSV viral load in BALF lies within high values such as 30% and above of ICU patient’s BALF samples. In the vast majority of positive samples of DNA the concentration of this virus was in the area of high values (up to 107 copies/ml).
Age over 50 years, and also such laboratory signs of immunodeficiency as neutropenia and/or hypogammaglobulinemia had no significant effect on the incidence rate of the development of herpes virus-associated pneumonia. There are no data evaluating the severity of virus-associated pneumonia against the background of immunodeficiency. There is no data describing the severity of the course of herpes virus associated pneumonia in patients with hematological malignancies.
About the Authors
D. S. Tikhomirov
National Research Center for Hematology
Russian Federation
Russian Federation
Tikhomirov Dmitry S., BD, PhD, senior researcher of the Laboratory of Viral Safety of Transfusions of Blood and Blood Components
Moscow, 126167
T. A. Garanzha
National Research Center for Hematology
Russian Federation
Moscow, 126167
Russian Federation
Moscow, 126167
T. A. Tupoleva
National Research Center for Hematology
Russian Federation
Russian Federation
Researcher ID: P-7607-2014
Moscow, 126167
V. V. Troitskaya
National Research Center for Hematology
Russian Federation
Researcher ID: M-8639-2014Moscow, 126167
Russian Federation
Researcher ID: M-8639-2014Moscow, 126167
G. M. Galstyan
National Research Center for Hematology
Russian Federation
Moscow, 126167
Russian Federation
Moscow, 126167
F. P. Filatov
National Research Center for Hematology
Russian Federation
Moscow, 126167
Russian Federation
Moscow, 126167
References
1. Pellett P.E., Roizman B. Herpes viridae. In: Knipe D.M., Howley P.M., Griffn D.E., Lamb R.A., Martin M.A., Roizman B., eds. Fields virology. Philadelphia: Lippincott Williams Wilkins; 2013. vol. 2: 1802–2080.
2. Volkova M.A. Clinical oncohematology. Guidelines for doctors. Мoscow: Meditsina; 2001. (in Russian)
3. Tikhomirov D.S., Garanzha T.A., Troitskaya V.V., Suvorova P.A., Yaroslavtseva N.G., Tupoleva T.A., et al. Laboratory diagnostic of herpes virus infections in patients with acute leukemia. Issues of Virology (Voprosy virusologii). 2009; 54(1): 19–21. (in Russian)
4. Melikyan A.L., Garanzha T.A., Tikhomirov D.S., Kaplanskaya I.В., Varlamova E.Yu., Kovalyova L.G., Filatov F.P. Epstein–Barr virus in patients with persistent lymphadenopathy. Hematology and Transfusiology. Russian Journal (Gematologiya i transfusiologiya). 2007; 4: 21–7. (in Russian)
5. Garanzha T.A., Tikhomirov D.S., Tupoleva T.A., Savchenko V.G., Filatov F.P. Diagnostic features of Epstein–Barr virus in patients with reduced immunity. Guide head of clinical diagnostic laboratory. Russian Journal (Spravochnik zaveduyushchego KDL). 2011; 8: 26–32. (in Russian)
6. Deayton J.R., Sabin C.A., Johnson M.A., Emery V.C., Wilson P., Griffths P.D. Importance of cytomegalovirus viremia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet. 2004; 363(9427): 2116–21.
7. Verschuuren E.A.M. Balance between Herpes Viruses and Immunosuppression after Lung Transplantation. Netherlands; 2006. ISBN 90-367-2869-X. http://www.rug.nl/research/portal/fles/2864452/thesis.pdf
8. Falcone E.L., Adegbulugbe A.A., Sheikh V., Imamichi H., Dewar R.L., Hammoud D.A., et al. Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis. Clin. Infect. Dis. 2013; 57(5): e135–42. doi: 10.1093/cid/cit356.
9. Razonable R.R., Fanning C., Brown R.A., Espy M.J., Rivero A., Wilson J., et al. Selective reactivation of human herpesvirus 6 variant A occurs in critically ill immunocompetent hosts. J. Infect. Dis. 2002; 185(1): 110–3.
10. Garanzha T.A., Tikhomirov D.S., Tupoleva T.A., Yaroslavtseva N.G., Filatov F.P. Comprehensive laboratory examination of patients with hematological malignancies with pneumonia. In: Proceedings of the 7th Congress of Hematology and Blood Transfusion of the Republic of Belarus “Actual problems of Hematology and Blood Transfusion», Minsk. 2012: 265–8. (in Russian)
11. Tikhomirov D.S., Garanzha T.A., Troitskaya V.V., Galstyan G.M., Parovichnikova E.N., Filatov F.P. Herpes virus infections in hematological patients with leucopenia during nosocomial pneumonia. Bulletin of Hematology. Russian journal (Vestnik gematologii). 2014; 4: 67–8. (in Russian)
12. Tikhomirov D.S., Garanzha T.A., Tupoleva T.A., Troitskaya V.V., Parovichnikova E.N., Galstyan G.M., et al. Laboratory diagnosis of herpesvirus infections in patients with hematological malignancies with pneumonia during chemotherapy. In: Proceedings of the XIX Annual conference “The Consolidation of science and practice in laboratory medicine”. Moscow, 25–27 March 2014. Moscow; 2014; 2: 15. (in Russian)
13. Garanzha T.A., Tikhomirov D.S., Tupoleva T.A., Troitskaya V.V., Parovichnikova E.N., Galstyan G.M., et al. Herpes virus associated pneumonia in patients with hematological malignancies. The role of molecular diagnostic methods. Proceedings of the VIII Annual conference “Molecular diagnostic 2014”, Moscow, 18–20 March, 2014. Moscow; 2014; 1: 302–3. (in Russian)
14. Galstyan G.M., Kesel’man S.A., Gorodetskiy V.M., Aleksanyan M.Zh., Kulikov S.M., Gemdzhyan E.G., et al. Acute respiratory failure treatment during hematological malignancy chemotherapy in ICU. Therapeutic archive. Russian Journal (Terapevticheskiy arkhiv). 2009; 12: 37–43. (in Russian)
15. Galstyan G.M., Glasko E.N., Gorodetskiy V.M., Grzhimolovskiy A.V., Danishyan K.I., Demidova I.A., et al. Lung biopsy useful for lung injury diagnosis in patients with hematological malignancies. Therapeutic archive. Russian Journal (Terapevticheskiy arkhiv). 2003; 75(10): 57–64. (in Russian)
16. Gondo H., Harada M., Minematsu T., Akashi K., Hayashi S., Taniguchi S., et al. Cytomegalovirus antigenemia in the differential diagnosis of pulmonary infltrates after allogeneic bone marrow transplantation. Rinsho Ketsueki. 1993: 34 (11): 1438–44.
17. Konoplev S., Champlin R.E., Giralt S., Ueno N.T., Khouri I., Raad I., et al. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant. 2001; 27(8): 877–81.
18. Nguyen Q., Champlin R., Giralt S., Rolston K., Raad I., Jacobson K., et al. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin. Infect. Dis. 1999; 28(3): 618–23.
19. Schuller D., Spessert C., Fraser V.J., Goodenberger D.M. Herpes simplex virus from respiratory tract secretions: epidemiology, clinical characteristics, and outcome in immunocompromised and nonimmunocompromised hosts. Am. J. Med. 1993; 94(1): 29–33.
20. van den Brink J.W., Simoons-Smit A.M., Beishuizen A., Girbes A.R., van Strack Schijndel R.J., Groeneveld A.B. Respiratory herpes simplex virus type 1 infection/olonization in the critically ill: marker or mediator? J. Clin. Virol. 2004; 30(1): 68–72.
21. Luyt C.E., Combes A., Deback C. Aubriot-Lorton M.H., Nieszkowska A., Trouillet J.L., et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am. J. Respir. Crit. Care Med. 2007; 175(9): 935–42. doi: 10.1164/rccm.200609-1322oc.
22. Bouza E., Giannella M., Torres M.V., Catalán P., Sánchez-Carrillo C., Hernandez R.I., Muñoz P.; Gregorio Marañón Task Force for Pneumonia. Herpes simplex virus: a marker of severity in bacterial ventilator-associated pneumonia. J. Crit. Care. 2011; 26(4): 432. e1–6. doi: 10.1016/j.jcrc.2010.10.008.
23. Assink-de Jong E., Groeneveld A.B., Pettersson A.M., Koek A., Vandenbroucke-Grauls C.M., Beishuizen A., Simoons-Smit A.M. Clinical correlates of herpes simplex virus type 1 loads in the lower respiratory tract of critically ill patients. J. Clin. Virol. 2013; 58(1): 79–83. doi: 10.1016/j.jcv.2013.05.007.
24. Gooskens J., Templeton K.E., Claas E.C., van Bussel M.J., Smit V.T., Kroes A.C. Quantitative detection of herpes simplex virus DNA in the lower respiratory tract. J. Med. Virol. 2007; 79(5): 597–604.
25. Lópea-Giraldo A., Sialer S., Esperatti M., Torres A. Viralreactivated pneumonia during mechanical ventilation: is there need antiviral treatment? Front. Pharmacol. 2011; 2: 66. doi: 10.3389/fphar.2011.00066.
26. Bruynseels P., Jorens P.G., Demey H.E., Goossens H., Pattyn S.R., Elseviers M.M., et al. Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet. 2003; 362(9395): 1536–41.
27. Linssen C. Diagnostic value of bronchoalveolar lavage in infectious disorders. 2007 ISBN: 978-90-5278-664-3. http://www.oud.ildcare.eu/Downloads/proefschriften/Thesis_Kitty_Linssen.pdf. Available on: http://dx.doi.org/10.1016/j.jcv.2013.05.007
28. Lasithiotaki I., Antoniou K.M., Vlahava V.M., Karagiannis K., Spandidos D.A., Siafakas N.M., Sourvinos G. Detection of herpes simplex virus type-1 in patients with fbrotic lung diseases. PLoS ONE. 2011; 6(12): e27800. doi:10.1371/journal.pone.0027800.
29. Frobert E., Billaud G., Casalegno J.S., Eibach D., Goncalves D., Robert J.M., et al. The clinical interest of HSV 1 semi-quantifcation in bronchoalveolar lavage. J. Clin. Virol. 2013; 58(1): 265–8. doi: 10.1016/j.jcv.2013.04.019.
Review
For citations:
Tikhomirov D.S., Garanzha T.A., Tupoleva T.A., Troitskaya V.V., Galstyan G.M., Filatov F.P. Factors affecting the incidence of viral pneumonia in patients with hematological malignancies. Russian journal of hematology and transfusiology. 2016;61(1):37-42. (In Russ.) https://doi.org/10.18821/0234-5730-2016-61-1-37-42
Views:
650
Email this article 
